(Q37385351)

20 August 2017

1 reference

title

Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors (English)

1 reference

20 August 2017

Marco Lazzaroni

1

1 reference

20 August 2017

Gabriele Bianchi Porro

series ordinal

2

1 reference

20 August 2017

publication date

1 January 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

69

1 reference

20 August 2017

issue

1

1 reference

20 August 2017

page(s)

51-69

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200969010-00004

20 August 2017

exact match

0 references

cites work

Epidemiology and pharmacoeconomic implications of non-steroidal anti-inflammatory drug-associated gastrointestinal toxicity

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969010-00004

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969010-00004

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969010-00004

Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969010-00004

Quality of life in arthritis patients using nonsteroidal anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969010-00004

Aspirin concurrently administered with ranitidine does not delay healing of duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969010-00004

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969010-00004

Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?

21 January 2018

1 reference

12 December 2020

Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials

1 reference

12 December 2020

Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin

1 reference

12 December 2020

Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis

1 reference

12 December 2020

Selective COX-2 Inhibitors: A Promise Unfulfilled?

1 reference

12 December 2020

Abolition by omeprazole of aspirin induced gastric mucosal injury in man.

1 reference

12 December 2020

Does famotidine have similar efficacy to misoprostol in the treatment of non-steroidal anti-inflammatory drug-induced gastropathy?

1 reference

12 December 2020

Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment

1 reference

12 December 2020

Prevention of chronic NSAID induced upper gastrointestinal toxicity

1 reference

12 December 2020

Omeprazole ameliorates aspirin-induced gastroduodenal injury

1 reference

12 December 2020

Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study

1 reference

12 December 2020

Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage

1 reference

12 December 2020

Prevention of NSAID-Induced Ulcers

1 reference

12 December 2020

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole

1 reference

12 December 2020

Treatment of NSAID-induced gastrointestinal lesions with cimetidine: an international multicentre collaborative study.

1 reference

12 December 2020

Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials

1 reference

12 December 2020

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

12 December 2020

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1 reference

12 December 2020

The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis

1 reference

12 December 2020

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

12 December 2020

Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer

1 reference

12 December 2020

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

12 December 2020

Effect of indomethacin on gastric acid and bicarbonate secretion in humans

1 reference

12 December 2020

[Protective effect of omeprazole on gastric lesions induced by a single dose of aspirin in man]

1 reference

12 December 2020

Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease

1 reference

12 December 2020

Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial

1 reference

12 December 2020

Unnecessary prescribing of NSAIDs and the management of NSAID-related gastropathy in medical practice

1 reference

12 December 2020

Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance

1 reference

12 December 2020

Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial.

1 reference

12 December 2020

Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse

1 reference

12 December 2020

National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation

1 reference

12 December 2020

The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis

1 reference

12 December 2020

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

1 reference

12 December 2020

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

1 reference

12 December 2020

Epidemiology of NSAID induced gastrointestinal complications.

1 reference

12 December 2020

Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users

1 reference

12 December 2020

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

1 reference

12 December 2020

The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs

1 reference

12 December 2020

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Protection against aspirin-induced gastric lesions by lansoprazole: simultaneous evaluation of functional and morphologic responses

1 reference

12 December 2020

A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use

1 reference

12 December 2020

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

1 reference

12 December 2020

Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole

1 reference

12 December 2020

Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed

1 reference

12 December 2020

Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications

1 reference

12 December 2020

Gastrointestinal side-effects of NSAIDs in the community.

1 reference

12 December 2020

Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin

1 reference

12 December 2020

Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs

1 reference

12 December 2020

Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies

1 reference

12 December 2020

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.

1 reference

12 December 2020

Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage

1 reference

12 December 2020

Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH.

1 reference

12 December 2020

Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients

1 reference

12 December 2020

NSAID-associated deaths: the rise and fall of NSAID-associated GI mortality

1 reference

12 December 2020

Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations

1 reference

12 December 2020

Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population

1 reference

12 December 2020

Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: a randomized trial

1 reference

12 December 2020

Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications

1 reference

12 December 2020

Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage

1 reference

12 December 2020

Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding

1 reference

12 December 2020

Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine

1 reference

12 December 2020

The mucoid cap over superficial gastric damage in the rat. A high-pH microenvironment dissipated by nonsteroidal antiinflammatory drugs and endothelin

1 reference

12 December 2020

Omeprazole attenuates oxygen-derived free radical production from human neutrophils

1 reference

12 December 2020

NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite.

1 reference

12 December 2020

Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects

1 reference

12 December 2020

Doubt and certainty about nonsteroidal anti-inflammatory drugs in the year 2000: a multidisciplinary expert statement

1 reference

12 December 2020

Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study

1 reference

12 December 2020

Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Intragastric acid control in non-steroidal anti-inflammatory drug users: comparison of esomeprazole, lansoprazole and pantoprazole

1 reference

12 December 2020

Omeprazole and sucralfate in the treatment of NSAID-induced gastric and duodenal ulcer

1 reference

12 December 2020

The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials

1 reference

12 December 2020

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

1 reference

12 December 2020

Cimetidine in the treatment of gastric ulcer induced by steroidal and nonsteroidal anti-inflammatory agents.

1 reference

12 December 2020

Helicobacter pylori infection and chronic gastric acid hyposecretion

1 reference

12 December 2020

Resistance to medical therapy of gastric ulcers in rheumatic disease patients taking aspirin. A double-blind study with cimetidine and follow-up.

1 reference

12 December 2020

Parenteral aspirin and sodium salicylate are equally injurious to the rat gastric mucosa

1 reference

12 December 2020

Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.

1 reference

12 December 2020

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

1 reference

12 December 2020

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

1 reference

12 December 2020

Effect of one-month treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients

1 reference

12 December 2020

Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds

1 reference

12 December 2020

Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group

1 reference

12 December 2020

Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease

1 reference

12 December 2020

Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury.

1 reference

12 December 2020

Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users

1 reference

12 December 2020

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

1 reference

12 December 2020

The cellular and molecular basis of gastric mucosal defense.

1 reference

12 December 2020

Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants

1 reference

12 December 2020

Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users

1 reference

12 December 2020

[Protective effect of omeprazole against low-dose acetylsalicylic acid. Endoscopic controlled double-blind study in healthy subjects]

1 reference

12 December 2020

Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen

1 reference

12 December 2020

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review

1 reference

12 December 2020

Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors

1 reference

12 December 2020

Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Double-blind long-term evaluation

1 reference

12 December 2020

Rapid protection of the gastroduodenal mucosa against aspirin-induced damage by rabeprazole

1 reference

12 December 2020

Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.

1 reference

12 December 2020

Selective COX-2 inhibitors, NSAIDs and cardiovascular events - is celecoxib the safest choice?

1 reference

12 December 2020

Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole

1 reference

12 December 2020

Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial

1 reference

12 December 2020

Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers

1 reference

12 December 2020

Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis

1 reference

12 December 2020

Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.

1 reference

12 December 2020

Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

12 December 2020

Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine

1 reference

12 December 2020

The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study

1 reference

12 December 2020

A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs.

1 reference

12 December 2020

The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events

1 reference

12 December 2020

Significant enhancement of gastric mucin content after rabeprazole administration: its potential clinical significance in acid-related disorders

1 reference

12 December 2020

[Studies on the protective effect of lansoprazole on human gastric mucosa against low-dose acetylsalicylic acid. An endoscopic controlled double-blind study]

1 reference

12 December 2020

From prostaglandin replacement to specific COX-2 inhibition: a critical appraisal

1 reference

12 December 2020

Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats

1 reference

12 December 2020

10.2165/00003495-200969010-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

20 August 2017

1042020188

0 references

1 reference